Skip to main content
Clinical Trials/NCT04708951
NCT04708951
Completed
Not Applicable

A Prospective Randomized Comparison of Colonoscopy Adenoma Detection Rate With a Disposable Cap (ENDOCUFF VISION®) (Endocuff) Versus a Permanently Mounted Balloon (G-EYE®)

Dr. Horst Schmidt Klinik GmbH3 sites in 2 countries970 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Adenoma
Sponsor
Dr. Horst Schmidt Klinik GmbH
Enrollment
970
Locations
3
Primary Endpoint
Comparison between adenoma detection rate of G-EYE® colonoscopy and EndoCuff Vision®
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The study is intended to compare the detection rate obtained by performing G-EYE® high definition colonoscopy vs. the detection rate obtained by performing ECV high definition colonoscopy.

Detailed Description

This is a multicenter, two-arm, randomized, open-label study intended to compare the detection rate obtained by performing G-EYE® high definition colonoscopy vs. the detection rate obtained by performing ECV high definition colonoscopy.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
October 15, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Dr. Horst Schmidt Klinik GmbH
Responsible Party
Principal Investigator
Principal Investigator

Prof. Dr. Ralf Kiesslich

Prof.

Dr. Horst Schmidt Klinik GmbH

Eligibility Criteria

Inclusion Criteria

  • Screening and surveillance population for Adenoma and CRC.
  • The patient must understand and sign a written informed consent for the procedure.

Exclusion Criteria

  • Subjects with inflammatory bowel disease;
  • Subjects with a personal history of hereditary polyposis syndrome;
  • Subjects with suspected chronic stricture potentially precluding complete colonoscopy;
  • Subjects with diverticulitis or toxic megacolon;
  • Subjects with prior colonic surgery (exclusion appendectomy)
  • Subjects with a history of radiation therapy to abdomen or pelvis;
  • Pregnant or lactating female subjects;
  • Subjects who are currently enrolled in another clinical investigation.
  • Subjects with current oral or parenteral use of anticoagulants, not considered eligible by the investigator.
  • Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke)

Outcomes

Primary Outcomes

Comparison between adenoma detection rate of G-EYE® colonoscopy and EndoCuff Vision®

Time Frame: June 2021

G-EYE® colonoscopy adenoma detection rate will be compared to the adenoma detection rate of EndoCuff Vision® colonoscopy. The primary performance measure is the adenoma detection rate (ADR), which is defined as the percentage of subjects with at least one adenoma found, in each of the study groups.

Study Sites (3)

Loading locations...

Similar Trials